148 related articles for article (PubMed ID: 38216690)
1. EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant.
Baranwal A; Mangaonkar A; Shah MV; Al-Kali A; Tefferi A; Hogan WJ; Litzow MR; Patnaik MM; Alkhateeb HB
Bone Marrow Transplant; 2024 Apr; 59(4):558-560. PubMed ID: 38216690
[No Abstract] [Full Text] [Related]
2. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
Liu HD; Ahn KW; Hu ZH; Hamadani M; Nishihori T; Wirk B; Beitinjaneh A; Rizzieri D; Grunwald MR; Sabloff M; Olsson RF; Bajel A; Bredeson C; Daly A; Inamoto Y; Majhail N; Saad A; Gupta V; Gerds A; Malone A; Tallman M; Reshef R; Marks DI; Copelan E; Gergis U; Savoie ML; Ustun C; Litzow MR; Cahn JY; Kindwall-Keller T; Akpek G; Savani BN; Aljurf M; Rowe JM; Wiernik PH; Hsu JW; Cortes J; Kalaycio M; Maziarz R; Sobecks R; Popat U; Alyea E; Saber W
Biol Blood Marrow Transplant; 2017 May; 23(5):767-775. PubMed ID: 28115276
[TBL] [Abstract][Full Text] [Related]
4. The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Mei M; Pillai R; Kim S; Estrada-Merly N; Afkhami M; Yang L; Meng Z; Abid MB; Aljurf M; Bacher U; Beitinjaneh A; Bredeson C; Cahn JY; Cerny J; Copelan E; Cutler C; DeFilipp Z; Diaz Perez MA; Farhadfar N; Freytes CO; Gadalla SM; Ganguly S; Gale RP; Gergis U; Grunwald MR; Hamilton BK; Hashmi S; Hildebrandt GC; Lazarus HM; Litzow M; Munker R; Murthy HS; Nathan S; Nishihori T; Patel SS; Rizzieri D; Seo S; Shah MV; Solh M; Verdonck LF; Vij R; Sobecks RM; Oran B; Scott BL; Saber W; Nakamura R
Haematologica; 2023 Jan; 108(1):150-160. PubMed ID: 35443559
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia].
Zhang XH; Zhou JY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):18-21. PubMed ID: 38527833
[TBL] [Abstract][Full Text] [Related]
6. Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia.
Woo J; Choi DR; Storer BE; Yeung C; Halpern AB; Salit RB; Sorror ML; Woolston DW; Monahan T; Scott BL; Deeg HJ
Haematologica; 2020 Mar; 105(3):652-660. PubMed ID: 31289199
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Wedge E; Hansen JW; Dybedal I; Creignou M; Ejerblad E; Lorenz F; Werlenius O; Ungerstedt J; Holm MS; Nilsson L; Kittang AO; Antunovic P; Rohon P; Andersen MK; Papaemmanuil E; Bernard E; Jädersten M; Hellström-Lindberg E; Grønbæk K; Ljungman P; Friis LS
Transplant Cell Ther; 2021 Dec; 27(12):991.e1-991.e9. PubMed ID: 34500124
[TBL] [Abstract][Full Text] [Related]
8. Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Kaivers J; Schuler E; Hildebrandt B; Betz B; Rautenberg C; Haas R; Kobbe G; Gattermann N; Germing U
Expert Rev Anticancer Ther; 2020 Aug; 20(8):703-714. PubMed ID: 32700646
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.
Gagelmann N; Bogdanov R; Stölzel F; Rautenberg C; Panagiota V; Becker H; Radujkovic A; Luft T; Christopeit M; Finke J; Platzbecker U; Ditschkowski M; Schroeder T; Koldehoff M; Heuser M; Kobbe G; Beelen DW; Germing U; Kröger N
Transplant Cell Ther; 2021 Jan; 27(1):95.e1-95.e4. PubMed ID: 33039516
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.
Krishnamurthy P; Lim ZY; Nagi W; Kenyon M; Mijovic A; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
Bone Marrow Transplant; 2010 Oct; 45(10):1502-7. PubMed ID: 20098454
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT.
Koenecke C; Eikema DJ; Hazelaar S; Schroeder T; Potter V; Kröger N; Bornhäuser M; Finke J; Platzbecker U; Radujkovic A; Ganser A; Salmenniem U; Blaise D; Kobbe G; Meijer E; Friis L; Maertens J; Caballero D; Cornelissen JJ; Olivieri A; Gulsum O; Hayden PJ; Onida F; Robin M; Yakoub-Agha I
Bone Marrow Transplant; 2022 Oct; 57(10):1607-1611. PubMed ID: 35871086
[No Abstract] [Full Text] [Related]
14. Contemporary treatment approaches to CMML - Is allogeneic HCT the only cure?
Robin M; Itzykson R
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101138. PubMed ID: 32460980
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.
Onida F; Sbianchi G; Radujkovic A; Sockel K; Kröger N; Sierra J; Socié G; Cornelissen J; Poiré X; Raida L; Bourhis JH; Finke J; Passweg J; Salmenniemi U; Schouten HC; Beguin Y; Martin S; Deconinck E; Ganser A; Zver S; Lioure B; Rohini R; Koster L; Hayden P; Iacobelli S; Robin M; Yakoub-Agha I
Bone Marrow Transplant; 2022 Jun; 57(6):896-902. PubMed ID: 35352038
[TBL] [Abstract][Full Text] [Related]
16. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
17. High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant.
Baranwal A; Mangaonkar A; Shah MV; Litzow MR; Hogan WJ; Patnaik MM; Alkhateeb HB
Bone Marrow Transplant; 2022 Dec; 57(12):1842-1844. PubMed ID: 36131003
[No Abstract] [Full Text] [Related]
18. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
[TBL] [Abstract][Full Text] [Related]
19. Isolated CNS relapse in FLT 3 mutation positive CMML post allogeneic stem cell transplant: Report of a rare case.
Mutreja D; Verma S; Venkatesan S; Sharma S; Das S
Indian J Pathol Microbiol; 2021; 64(1):189-191. PubMed ID: 33433440
[TBL] [Abstract][Full Text] [Related]
20. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.
Itonaga H; Iwanaga M; Aoki K; Aoki J; Ishiyama K; Ishikawa T; Sakura T; Fukuda T; Najima Y; Yujiri T; Mori T; Kurokawa M; Nawa Y; Uchida N; Morishita Y; Hashimoto H; Eto T; Hirokawa M; Morishima Y; Nagamura-Inoue T; Atsuta Y; Miyazaki Y
Leuk Res; 2016 Feb; 41():48-55. PubMed ID: 26754557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
